$39.67
-0.13-0.33%
At close: -
$40.08
0.411.03%
After Hours: 9:29 AM EDT
Comments
Loading...
Qiagen Analyst Ratings and Price Targets | NYSE:QGEN | Benzinga
Qiagen NV has a consensus price target of $49.44 based on the ratings of 11 analysts. The high is $60 issued by Citigroup on February 8, 2024. The low is $42 issued by Baird on February 19, 2025. The 3 most-recent analyst ratings were released by Baird, UBS, and Morgan Stanley on February 19, 2025, February 7, 2025, and January 6, 2025, respectively. With an average price target of $46 between Baird, UBS, and Morgan Stanley, there's an implied 14.77% upside for Qiagen NV from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
UBS
Morgan Stanley
Jefferies
Wolfe Research
1calculated from analyst ratings
Analyst Ratings for Qiagen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | Buy Now | 4.79% | Baird | Catherine Schulte68% | $52 → $42 | Downgrade | Outperform → Neutral | Get Alert |
| 02/07/2025 | Buy Now | 19.76% | UBS | John Sourbeer30% | $50 → $48 | Maintains | Neutral | Get Alert |
| 01/06/2025 | Buy Now | 19.76% | Morgan Stanley | Steve Beuchaw64% | $51.5 → $49.44 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/10/2024 | Buy Now | 34.73% | Jefferies | Tycho Peterson82% | $43.26 → $55.62 | Assumes | Hold → Buy | Get Alert |
| 10/17/2024 | Buy Now | — | HSBC | Shubhangi Gupta7% | — | Downgrade | Buy → Hold | Get Alert |
| 08/02/2024 | Buy Now | 29.74% | Baird | Catherine Schulte68% | $50.47 → $53.56 | Maintains | Outperform | Get Alert |
| 06/27/2024 | Buy Now | 24.75% | Wolfe Research | Doug Schenkel71% | → $51.5 | Upgrade | Peer Perform → Outperform | Get Alert |
| 06/18/2024 | Buy Now | 34.73% | JP Morgan | Casey Woodring28% | $53.56 → $55.62 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | 12.28% | Stifel | Daniel Arias66% | $56.65 → $46.35 | Maintains | Hold | Get Alert |
| 02/16/2024 | Buy Now | 27.25% | Morgan Stanley | Steve Beuchaw64% | $50.96 → $52.53 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/08/2024 | Buy Now | 29.74% | JP Morgan | Casey Woodring28% | $51.5 → $53.56 | Maintains | Overweight | Get Alert |
| 02/08/2024 | Buy Now | 49.7% | Citigroup | Patrick Donnelly80% | $63.72 → $61.8 | Maintains | Buy | Get Alert |
| 12/20/2023 | Buy Now | 24.75% | JP Morgan | Casey Woodring28% | $47.74 → $53.05 | Maintains | Overweight | Get Alert |
| 12/19/2023 | Buy Now | 9.78% | Wells Fargo | Timothy Daley53% | → $46.68 | Initiates | → Equal-Weight | Get Alert |
| 12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel71% | — | Initiates | → Peer Perform | Get Alert |
| 12/07/2023 | Buy Now | — | Goldman Sachs | Matthew Sykes66% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/02/2023 | Buy Now | 4.79% | UBS | John Sourbeer30% | $50.92 → $44.56 | Maintains | Neutral | Get Alert |
| 10/17/2023 | Buy Now | 24.75% | JP Morgan | Casey Woodring28% | $58.35 → $53.05 | Maintains | Overweight | Get Alert |
| 09/26/2023 | Buy Now | 49.7% | Citigroup | Patrick Donnelly80% | $63.65 → $63.65 | Reiterates | Buy → Buy | Get Alert |
| 09/12/2023 | Buy Now | 24.75% | Baird | Catherine Schulte68% | → $53.05 | Initiates | → Outperform | Get Alert |
| 08/09/2023 | Buy Now | 19.76% | UBS | John Sourbeer30% | $53.05 → $50.92 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 29.74% | UBS | John Sourbeer30% | $53.05 → $55.17 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | 49.7% | Citigroup | Patrick Donnelly80% | $58.35 → $63.65 | Maintains | Buy | Get Alert |
| 11/09/2022 | Buy Now | 37.23% | Citigroup | Patrick Donnelly80% | $65.78 → $58.35 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Qiagen (QGEN) stock?
The latest price target for Qiagen (NYSE:QGEN) was reported by Baird on February 19, 2025. The analyst firm set a price target for $42.00 expecting QGEN to rise to within 12 months (a possible 4.79% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Qiagen (QGEN)?
The latest analyst rating for Qiagen (NYSE:QGEN) was provided by Baird, and Qiagen downgraded their neutral rating.
When was the last upgrade for Qiagen (QGEN)?
The last upgrade for Qiagen NV happened on June 27, 2024 when Wolfe Research raised their price target to $50. Wolfe Research previously had a peer perform for Qiagen NV.
When was the last downgrade for Qiagen (QGEN)?
The last downgrade for Qiagen NV happened on February 19, 2025 when Baird changed their price target from $52 to $42 for Qiagen NV.
When is the next analyst rating going to be posted or updated for Qiagen (QGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Qiagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Qiagen was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.
Is the Analyst Rating Qiagen (QGEN) correct?
While ratings are subjective and will change, the latest Qiagen (QGEN) rating was a downgraded with a price target of $52.00 to $42.00. The current price Qiagen (QGEN) is trading at is $40.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.